Rising Surgical Volumes and Advanced Materials Support Market Expansion
The Artificial Hip Joint Market continues to show consistent momentum as global demand for hip replacement procedures increases. According to the latest industry assessment, the market size escalated to USD 7.66 billion by the end of 2023 and is projected to reach USD 9.82 billion by 2031, expanding at a healthy CAGR of 3.6% from 2024 to 2031. This upward trend is strongly linked to the rising prevalence of osteoarthritis, osteoporosis, and injury-associated mobility disorders that are influencing a growing patient need for durable and effective hip reconstruction solutions.
Improved surgical outcomes and rapid adoption of precision-driven orthopedic techniques continue to elevate the market outlook. Surgeons are increasingly choosing advanced implants that provide greater mobility, longer operational life, and reduced complications. This shift, supported by device innovation and integration of personalized approaches, is pushing manufacturers to broaden their portfolios and enhance performance reliability. As hospitals and orthopedic centers adopt next-generation technologies, the global landscape reflects a steady climb in procedure volumes and patient trust in modern hip replacement solutions.
This market growth is also boosted by an aging global population, increased sports injuries, and lifestyle changes that contribute to joint degeneration. Patients today are more aware of treatment options and seek high-quality implants with minimal recovery time. The combination of these factors is expected to sustain long-term demand and open new pathways for industry players during the forecast period.
Get free Sample Report@ https://www.snsinsider.com/sample-request/1009
The market’s segmentation highlights several standout categories that shape its overall trajectory. Among product types, primary hip replacement devices lead with over USD 5.49 billion in value for 2023. Their dominance stems from improved surgical success rates, patient mobility benefits, and device enhancements optimized for diverse anatomical requirements. Technological advancements in implant design and customization also contribute to higher adoption in hospitals and orthopedic centers.
The material segment is another crucial driver, with metal-on-plastic solutions valued at over USD 4.22 billion in 2023. Their affordability, durability, and wide clinical acceptance make them the preferred choice among surgeons. The combination of stainless steel or titanium with polyethylene continues to deliver strong clinical outcomes, particularly for elderly patients and individuals with lower activity levels. Ongoing advancements aim to reduce wear rates and offer better longevity, reinforcing their strong market position.
Fixation materials reflect a promising growth outlook, especially cemented fixation systems, which are projected to reach over USD 762 million by 2031. These systems demonstrate a high implant survival rate and remain particularly reliable for older patients, offering a strong bond between bone and implant. The use of fast-curing bone cement, often with added antibiotics, supports better surgical safety and improved postoperative results. With growing emphasis on long-term stability and low infection risk, cemented fixation methods maintain market traction.
Insert choices play an equally influential role in market expansion. Cross-linked polyethylene inserts are expected to reach over USD 3.43 billion by 2031, driven by their ability to reduce wear and extend implant life. Clinical case studies reflect high success rates, making them the preferred choice for surgeons looking for predictable long-term outcomes. These inserts support improved mobility and reduce revision surgery risks, key benefits contributing to their continued market dominance.
Hospitals remain the primary end-use segment, holding more than 83% market share in 2023. Their dominance is supported by extensive infrastructure, advanced equipment, skilled orthopedic specialists, and comprehensive post-surgery care. Patients rely heavily on hospitals for hip replacement procedures due to improved recovery pathways and integrated physical therapy services. This trend is expected to persist as demand for minimally invasive and specialized care increases globally.
Regionally, North America leads the market, supported by strong healthcare systems, rising orthopedic procedure rates, and a robust presence of leading manufacturers. Favorable reimbursement programs further boost patient access to hip replacement surgeries. Additionally, increasing cases of sports injuries and age-related joint disorders contribute significantly to regional growth. Asia Pacific, on the other hand, is projected to showcase noteworthy expansion driven by rising healthcare investments, medical tourism, aging demographics, and growing rates of obesity and bone disorders. Countries across this region are strengthening healthcare infrastructure, which encourages higher procedure adoption and market penetration.
The Artificial Hip Joint Market includes major global players such as Johnson and Johnson, Medacta International, Stryker Corporation, B. Braun, Zimmer Biomet Holdings, Microport Orthopedics, Smith and Nephew, DJO Global, and Exactech. These companies continue to invest in innovation, product upgrades, and strategic expansions to address evolving clinical needs and improve patient outcomes.
Recent advancements also reflect strong innovation efforts within the industry. In January 2023, Hip Innovation Technology began testing the Reverse Hip Replacement System in the United States, marking a significant step in new device evaluation. In March 2022, DePuy Synthes acquired the CUPTIMIZE Hip-Spine Analysis tool, enhancing surgeons’ ability to assess pelvic tilt and perform more precise hip replacement procedures.
As global demand for improved mobility and joint health rises, industry leaders remain focused on advancing materials, enhancing implant longevity, and adopting precision technologies. With strong patient confidence and expanding access to orthopedic care, the Artificial Hip Joint Market is positioned for stable and impactful growth through 2031.
Other Trending Reports
Menstrual Pain Relief Patches Market Growth
Geographic Atrophy (GA) Market Growth
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Rohan Jadhav – Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
